Skip to main content
Erschienen in: Endocrine Pathology 3/2016

28.05.2016

Synchronous Papillary Carcinoma of Thyroid and Lung

verfasst von: Tao Wang, Ian Blumer, Scott Boerner, Sylvia L. Asa

Erschienen in: Endocrine Pathology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Excerpt

A woman in her 1960s with a heavy smoking history had an incidental 1.5-cm left lower lobe lung lesion on chest x-ray. Biopsy diagnosed an adenocarcinoma. PET scan showed avidity corresponding to the lung nodule but also in the thyroid. Ultrasonography confirmed a 6-cm solid and cystic lesion in the right thyroid, which underwent fine needle aspiration (FNA) and revealed papillary thyroid carcinoma. Due to her severe chronic obstructive pulmonary disease, she was not a candidate for surgery. The lung nodule was treated with radiotherapy while the thyroid nodule was left untreated and followed over 7 years. Follow-up imaging did not show the thyroid nodule to have increased in size, and indeed, a recent thyroid ultrasound reported a nodule not exceeding 4.8 cm in maximal diameter; this nodule was primarily cystic. At a 7-year follow-up visit, thyroid indices revealed the onset of hyperthyroidism with an undetectably low TSH, an elevated free T3 of 9.4 pMol/L (upper normal 5.7), and a normal free T4 of 20 pMol/L (upper normal 22). Nuclear medicine imaging documented increased iodine uptake of 35 % (upper normal 32 %) with a cold defect corresponding to the large nodule seen on ultrasonography. No focal area of increased uptake was observed. The patient declined thyroid receptor-stimulating antibody testing. …
Literatur
1.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al (2015) American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133.CrossRef Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al (2015) American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133.CrossRef
2.
Zurück zum Zitat Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552.CrossRefPubMed Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552.CrossRefPubMed
3.
Zurück zum Zitat Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386–391.CrossRefPubMed Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386–391.CrossRefPubMed
4.
Zurück zum Zitat Asioli S, Erickson LA, Righi A, Lloyd RV (2013) Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320–328.CrossRefPubMed Asioli S, Erickson LA, Righi A, Lloyd RV (2013) Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320–328.CrossRefPubMed
5.
Zurück zum Zitat Khoo MLC, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ, Asa SL (2002) Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128:253-257.CrossRefPubMed Khoo MLC, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ, Asa SL (2002) Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128:253-257.CrossRefPubMed
6.
Zurück zum Zitat Khoo MLC, Beasley NJP, Ezzat S, Freeman JL, Asa SL (2002) Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastasis in papillary thyroid carcinoma. J Clin Endocrinol Metab 87:1814-1818.CrossRefPubMed Khoo MLC, Beasley NJP, Ezzat S, Freeman JL, Asa SL (2002) Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastasis in papillary thyroid carcinoma. J Clin Endocrinol Metab 87:1814-1818.CrossRefPubMed
7.
Zurück zum Zitat Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N (2008) Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters. Croat Med J 49:643–649.CrossRefPubMedPubMedCentral Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N (2008) Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters. Croat Med J 49:643–649.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Londero SC, Godballe C, Krogdahl A, Bastholt L, Specht L, Sørensen CH, et al (2008) Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol 47:451–457.CrossRefPubMed Londero SC, Godballe C, Krogdahl A, Bastholt L, Specht L, Sørensen CH, et al (2008) Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol 47:451–457.CrossRefPubMed
9.
Zurück zum Zitat Cheng S, Serra S, Mercado M, Ezzat S, Asa SL (2011) A High-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 17:2385-2394 Cheng S, Serra S, Mercado M, Ezzat S, Asa SL (2011) A High-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 17:2385-2394
10.
Zurück zum Zitat Dencic TMI, Savin SB, Selemetjev SA, Paskas SD, Zivaljevic VR, Bozic VD, et al (2015) Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma. Pathol Oncol Res 21:735–742.CrossRefPubMed Dencic TMI, Savin SB, Selemetjev SA, Paskas SD, Zivaljevic VR, Bozic VD, et al (2015) Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma. Pathol Oncol Res 21:735–742.CrossRefPubMed
11.
Zurück zum Zitat Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690.CrossRef Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690.CrossRef
12.
Zurück zum Zitat Dettmer MS, Schmitt A, Steinert H et al. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 2015; 22(3):419-429.CrossRefPubMed Dettmer MS, Schmitt A, Steinert H et al. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 2015; 22(3):419-429.CrossRefPubMed
13.
Zurück zum Zitat Bullock M, Ren Y, O’Neill C, Gill A, Aniss A, Sywak M, et al (2015) TERT Promoter Mutations Are a Major Indicator of Recurrence and Death due to Papillary Thyroid Carcinomas. Clin Endocrinol [Epub ahead of print] Bullock M, Ren Y, O’Neill C, Gill A, Aniss A, Sywak M, et al (2015) TERT Promoter Mutations Are a Major Indicator of Recurrence and Death due to Papillary Thyroid Carcinomas. Clin Endocrinol [Epub ahead of print]
Metadaten
Titel
Synchronous Papillary Carcinoma of Thyroid and Lung
verfasst von
Tao Wang
Ian Blumer
Scott Boerner
Sylvia L. Asa
Publikationsdatum
28.05.2016
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 3/2016
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9435-6

Weitere Artikel der Ausgabe 3/2016

Endocrine Pathology 3/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie